Published in Arthritis Rheumatol on May 04, 2017
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 20.30
The hallmarks of aging. Cell (2013) 14.29
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med (2003) 11.23
RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell (2009) 10.11
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol (2009) 7.74
A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity (2008) 5.89
The comet assay: a method to measure DNA damage in individual cells. Nat Protoc (2006) 5.11
Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer (2009) 5.02
RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med (2005) 4.85
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet (2007) 4.76
Mitochondria in innate immune responses. Nat Rev Immunol (2011) 3.31
Pathogenesis of systemic lupus erythematosus. J Clin Pathol (2003) 2.93
Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol (2014) 2.58
Microarray analysis of interferon-regulated genes in SLE. Autoimmunity (2003) 2.24
Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity (2012) 2.23
Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells (2007) 2.12
DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol Biol Cell (2006) 1.78
Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells (2009) 1.72
Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat Cell Biol (2011) 1.55
Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest (2014) 1.50
Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol (2008) 1.43
Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop. J Immunol (2009) 1.42
A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Mol Med (2011) 1.29
Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus (2007) 1.26
Mitochondrial antiviral signaling protein plays a major role in induction of the fish innate immune response against RNA and DNA viruses. J Virol (2009) 1.25
Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res Ther (2014) 1.22
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE). Ann Rheum Dis (2015) 1.12
The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol (2015) 1.09
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation. Lupus (2011) 1.05
Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol (2013) 1.01
DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function. Cell Rep (2015) 1.01
Potential role of IFNα in adult lupus. Arthritis Res Ther (2010) 0.98
Update on mesenchymal stem cell-based therapy in lupus and scleroderma. Arthritis Res Ther (2015) 0.93
An essential role for IFN-β in the induction of IFN-stimulated gene expression by LPS in macrophages. J Leukoc Biol (2014) 0.92
Osteoporosis in patients with systemic lupus erythematosus. Isr Med Assoc J (2009) 0.89
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases. Gene (2015) 0.87
Reactive oxygen species damage to DNA and its role in systemic lupus erythematosus. Mol Aspects Med (1991) 0.86
TAK1 regulates SOX9 expression in chondrocytes and is essential for postnatal development of the growth plate and articular cartilages. J Cell Sci (2013) 0.86
Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A. Arthritis Rheumatol (2014) 0.85
Possible association of VISA gene polymorphisms with susceptibility to systemic lupus erythematosus in Chinese population. Mol Biol Rep (2010) 0.85
Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway. Mol Cell Biochem (2013) 0.84
Human effector B lymphocytes express ARID3a and secrete interferon alpha. J Autoimmun (2016) 0.84
Differential efficacy of human mesenchymal stem cells based on source of origin. J Immunol (2014) 0.84
Dysregulation of antiviral helicase pathways in systemic lupus erythematosus. Front Genet (2014) 0.82
Alteration of Antiviral Signalling by Single Nucleotide Polymorphisms (SNPs) of Mitochondrial Antiviral Signalling Protein (MAVS). PLoS One (2016) 0.75
Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis. Arthritis Rheumatol (2016) 0.83